Purpose: There is uncertainty as to which anticoagulant should be used in non-valvular
atrial fibrillation (AF) with valvular heart disease. This systematic review and meta-analysis …

OBJECTIVE To examine the association of aortic valve sclerosis (AVS) and mitral annulus
calcification (MAC) with all-cause and cardiovascular mortality in type 2 diabetic individuals …

Objective To compare the characteristics and outcomes of patients with atrial fibrillation (AF)
and aortic stenosis (AS) with patients with AF with mitral regurgitation (MR) or aortic …

Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Background: Systemic thromboembolism is a serious complication in patients with aortic
stenosis (AS). Previous studies have demonstrated that platelet activation occurs in patients …

Thromboembolic events, primarily stroke, might complicate transcatheter aortic-valve
implantation (TAVI) procedures in 3–5% of cases. Thus, it is common to administer aspirin …

Mitral annular calcification (MAC) is associated with several cardiovascular disorders
including coronary artery disease (CAD), atherosclerosis, heart failure, and stroke. MAC and …

Platelets and clotting cascade play a major role in development of atrial thrombus in patients
with atrial fibrillation. The mean platelet volume (MPV) reflects platelet size and is …

Background: There are limited data for non-vitamin K antagonist oral anticoagulants
(NOACs) impact on outcomes for patients with atrial fibrillation (AF) and valvular heart …

Background: Previous studies have demonstrated that platelet activation occurs in patients
with aortic stenosis (AS). This study sought to evaluate the changes in hematologic and …